Enveric Biosciences Files 8-K on Security Holder Matters
Ticker: ENVB · Form: 8-K · Filed: Jan 21, 2025 · CIK: 890821
| Field | Detail |
|---|---|
| Company | Enveric Biosciences, Inc. (ENVB) |
| Form Type | 8-K |
| Filed Date | Jan 21, 2025 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-rights, filing
TL;DR
Enveric Biosciences filed an 8-K detailing changes to shareholder rights and upcoming votes.
AI Summary
Enveric Biosciences, Inc. filed an 8-K on January 21, 2025, reporting on events that occurred on January 17, 2025. The filing indicates material modifications to security holder rights, amendments to its articles of incorporation or bylaws, and the submission of matters to a vote of security holders. It also includes financial statements and exhibits.
Why It Matters
This 8-K filing signals significant corporate actions and potential changes affecting Enveric Biosciences' shareholders, including voting matters and modifications to their rights.
Risk Assessment
Risk Level: medium — Filings related to material modifications of security holder rights and amendments to corporate governance documents can indicate significant changes that may impact the company's stock value and investor confidence.
Key Players & Entities
- Enveric Biosciences, Inc. (company) — Registrant
- January 17, 2025 (date) — Earliest event date
- January 21, 2025 (date) — Filing date
FAQ
What specific material modifications were made to the rights of Enveric Biosciences' security holders?
The filing indicates material modifications to the rights of security holders, but the specific details of these modifications are not provided in the summary information.
What amendments were made to Enveric Biosciences' articles of incorporation or bylaws?
The filing states that amendments to the articles of incorporation or bylaws were submitted, but the specific nature of these amendments is not detailed in the provided text.
What matters were submitted to a vote of Enveric Biosciences' security holders?
The filing confirms the submission of matters to a vote of security holders, but the specific proposals or issues to be voted on are not outlined in the summary.
When did the events reported in this 8-K filing occur?
The earliest event reported in this 8-K filing occurred on January 17, 2025.
What is the primary business of Enveric Biosciences, Inc. according to its SIC code?
Enveric Biosciences, Inc. is classified under the Standard Industrial Classification code 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 1,259 words · 5 min read · ~4 pages · Grade level 11.2 · Accepted 2025-01-21 17:10:33
Key Financial Figures
- $0.01 — ch registered Common stock, par value $0.01 per share ENVB The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 51KB
- ex3-1.htm (EX-3.1) — 16KB
- 0001493152-25-003091.txt ( ) — 246KB
- envb-20250117.xsd (EX-101.SCH) — 3KB
- envb-20250117_lab.xml (EX-101.LAB) — 33KB
- envb-20250117_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 21, 2025 ENVERIC BIOSCIENCES, INC. By: /s/ Joseph Tucker Joseph Tucker Chief Executive Officer